The number of omicron cases has risen to 174 in the country with a number of states reporting fresh infections.
Meanwhile, the Indian Council of Medical Research (ICMR) has designed a diagnostic kit for the detection of Omicron, the most recent variant of COVID-19 that is spreading across the globe. ICMR has also sought expression of interest from In-Vitro Diagnostics (IVD) kit manufacturers for transfer of technology for its development and commercialization. According to reports, Bharat Biotech, Indian pharma major has sought approval for phase-3 trials of its intranasal vaccine in the wake of rising number of cases.
The World Health Organization (WHO) has stated that the Omicron variant of the coronavirus is spreading faster than the Delta variant and is causing infections in people already vaccinated or who have recovered from the COVID-19 disease. WHO officials have also shared that Omicron looks to be better at evading antibodies generated by some COVID-19 vaccines. However, there are other forms of immunity that may prevent infection and disease.
Union Health Minister Mansukh Mandaviya informed that the states and union territories have adequate quantities of vaccines against Covid-19 for vaccination drives, adding that the country’s vaccine manufacturing capacity has also increased. Omicron cases have been detected in Maharashtra, Delhi, Rajasthan, Karnataka, Telangana, Gujarat, Kerala, Andhra Pradesh, Chandigarh, Tamil Nadu and West Bengal.